(1)
Desar, I. M. E.; Bovenschen, H. J.; Timmer-Bonte, A. J. N. H.; Cantarini, M. V.; van der Graaf, W. T. A.; van Rossum, M. M.; van Herpen, C. M. L. Case Studies Showing Clinical Signs and Management of Cutaneous Toxicity of the MEK1 2 Inhibitor AZD6244 (ARRY-142886) in Patients With Solid Tumours. AO 2010, 49, 113-116.